Michael H. Thomas

Bionostics Plc manufactured medical instruments and devices. Its products included Unidose glucose control packs, ribonucleic acid (RNA) medical blood-gas controls, and control for measuring hemoglobin and RNA medical safe wrap capillary tubes. The company was incorporated on March 27, 1954 and was headquartered in Southampton, the United Kingdom.

GLYCODesign, Inc. develops pharmaceutical products. The company engages in the discovery and development of novel therapeutics for life-threatening diseases such as cancer, infectious diseases, inflammation, and cardiovascular diseases. GLYCODesign focuses on inhibiting the enzymes that produce the abnormal carbohydrates. The company was founded by Jeremy Carver in 1993 and is headquartered in Toronto, Canada.

DSM Pharmaceuticals, Inc. provides contract manufacturing services to the pharmaceutical and biotechnology industries. It offers manufacturing services in the areas of sterile, and orals & topical, including dose form manufacturing, scheduled drugs, clinical manufacturing, fill finish manufacturing, aseptic filling, terminal sterilization, cold storage, ampoules, vials, and lyophilization. The company is headquartered in Greenville, NC.

R.P. Scherer Corp. Develops and manufactures oral drug delivery systems. The company offers different types of medical services and products. It has approximately 4 medical faculties in United States. The company is located in Troy, MI

Bayer, Inc. manufactures chemicals, healthcare, agricultural, and life science products. The company develops products that fight diseases, protects crops and animals, as well as develops materials. It was founded in 1936 and is headquartered in Toronto, Canada

Bio-Techne is a life sciences company founded in 1981 that provides innovative tools and bioactive reagents for the research and clinical diagnostic communities. The company is based in Devens, MA. The company's products aid in scientific investigations into biological processes and the nature and progress of specific diseases, drug discovery efforts, and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $1.10 billion in net sales in fiscal 2023 and has approximately 3,200 employees worldwide.